Neoadjuvant transarterial infusion chemotherapy with FOLFOX could improve outcomes of resectable BCLC stage A/B hepatocellular carcinoma patients beyond Milan criteria: An interim analysis of a multi-center, phase 3, randomized, controlled clinical trial.Shaohua Li, Rong Guo, Lie Zheng et al.|Journal of Clinical Oncology|2021Cited by 30
Transarterial infusion chemotherapy with FOLFOX for advanced hepatocellular carcinoma: a multi-center propensity score matched analysis of real-world practiceShaohua Li, Rong Guo, Jie Mei et al.|HepatoBiliary Surgery and Nutrition|2021Cited by 26
Real-world outcomes of patients with advanced intrahepatic cholangiocarcinoma treated with programmed cell death protein-1-targeted immunotherapyMin Deng, Rong Guo, Shaohua Li et al.|Annals of Medicine|2022Cited by 22
Resection vs. Sorafenib for Hepatocellular Carcinoma With Macroscopic Vascular Invasion: A Real World, Propensity Score Matched Analytic StudyJie Mei, Rong Guo, Shaohua Li et al.|Frontiers in Oncology|2020Cited by 17
Selenium-containing polyurethane nanofibers with MnO2 nanoparticles and gelsevirine promote diabetic wound healing by modulation of ROS and inflammationWajiha Ahmed, Changyou Gao, Shifen Li et al.|Biomaterials Advances|2025Cited by 11